Investor Calendar

Remedy publishes the financial statements release, two business reviews and the half-year review according to the disclosed annual schedule.

 

Event Date
Silent period and closed window January 11 – February 10, 2023
Financial statement release 2022 February 10, 2023
Annual report, Financial Statements and Board of Directors’ report 2022 Week 12 / 2023
Silent period and closed window March 27 – April 26, 2023
Annual General Meeting 2023 April 13, 2023
Business review for January-March 2023 April 26, 2023
Silent period and closed window July 12 – August 11, 2023
Half-year financial report for January-June 2023 August 11, 2023
Silent period and closed window October 1 – October 31, 2023
Business review for January-September 2023 October 31, 2023

Regularly published financial reports are always preceded by a silent period of 30 days, during which Remedy does not issue statements on the financial position, business operations, markets or prospects.

During the silent period, the senior management of the company does not meet with investors, analysts or other capital market representatives, nor do they give interviews on the financial position of the company.